The PPMD team is joined by leading Duchenne researchers to discuss exciting areas of research in development that hold promise for Duchenne, such as gene editing and non-viral delivery. Panelists: Kevin Flanigan, MD, Nationwide Children’s Hospital Melissa Spencer, PhD, UCLA 6 years ago 2020 PPMD Virtual Conference: Live Sessions,Conferences & Meetings You may also like 21:45 Audentes Therapeutics 6 years ago Conferences & Meetings,In the Pipeline: Gene Therapy gene therapy 19:10 Solid Biosciences 6 years ago Conferences & Meetings,In the Pipeline: Gene Therapy gene therapy 13:05 Astellas Pharma 6 years ago Conferences & Meetings,In the Pipeline: Downstream Targets 12:31 Santhera Pharmaceuticals 6 years ago Conferences & Meetings,In the Pipeline: Downstream Targets 10:23 Cumberland Pharmaceuticals 6 years ago Conferences & Meetings,In the Pipeline: Downstream Targets 7:11 Epirium Bio 6 years ago Conferences & Meetings,In the Pipeline: Downstream Targets 18:36 Sarepta Therapeutics (RNA Targeted Therapies) 6 years ago Conferences & Meetings,In the Pipeline: Restoring Dystrophin 11:46 NS Pharma 6 years ago Conferences & Meetings,In the Pipeline: Restoring Dystrophin «1…2122232425…28»Page 23 of 28